Seres Therapeutics Stock Forecast
Volatile ride for Seres Therapeutics stock price on Friday moving between $0.540 and $0.606
(Updated on Apr 19, 2024)
The Seres Therapeutics stock price fell by -4.16% on the last day (Friday, 19th Apr 2024) from $0.584 to $0.560. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 12.22% from a day low at $0.540 to a day high of $0.606. The price has fallen in 9 of the last 10 days and is down by -26.58% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -54 thousand shares and in total, 4 million shares were bought and sold for approximately $2.05 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.511 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -41.66% during the next 3 months and, with a 90% probability hold a price between $0.298 and $0.516 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
MCRB Signals & Forecast
There are few to no technical positive signals at the moment. The Seres Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.623 and $0.790. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -54.48%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Seres Therapeutics stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0660 between high and low, or 12.22%. For the last week, the stock has had daily average volatility of 9.02%.
Seres Therapeutics is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (MCRB) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Seres Therapeutics to open at $0.569, and during the day (based on 14 day Average True Range), to move between $0.502 and $0.618, which gives a possible trading interval of +/-$0.0581 (+/-10.38%) up or down from last closing price. If Seres Therapeutics takes out the full calculated possible swing range there will be an estimated 20.77% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $0.627, some $0.0674 (12.04%) from the current price of $0.560, our system finds the risk reward not very attractive.
Is Seres Therapeutics stock A Buy?
Seres Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -6.407 Strong Sell Candidate Unchanged
Predicted Opening Price for Seres Therapeutics of Monday, April 22, 2024
| Fair opening price April 22, 2024 | Current price |
|---|---|
| $0.569 ( 1.56%) | $0.560 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for MCRB
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.635 | 13.35 % | |
| R2 | 0.609 | 8.84 % | ||
| R1 | 0.594 | 6.06 % | ||
| Current price: | 0.560 | |||
| Support | S1 | 0.543 | -2.94 % | |
| S2 | 0.528 | -5.73 % | ||
| S3 | 0.503 | -10.23 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.689 | 23.13 % | |
| R2 | 0.682 | 21.84 % | ||
| R1 | 0.627 | 12.04 % | ||
| Current price | 0.560 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Seres Therapeutics Stock.
